Review




Structured Review

Addgene inc myc tcf
Myc Tcf, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/myc tcf/product/Addgene inc
Average 93 stars, based on 9 article reviews
myc tcf - by Bioz Stars, 2026-04
93/100 stars

Images



Similar Products

93
Addgene inc myc tcf
Myc Tcf, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/myc tcf/product/Addgene inc
Average 93 stars, based on 1 article reviews
myc tcf - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

92
Addgene inc myc tcf dominant negative
Myc Tcf Dominant Negative, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/myc tcf dominant negative/product/Addgene inc
Average 92 stars, based on 1 article reviews
myc tcf dominant negative - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

93
Addgene inc human full length pdlim7 expression plasmid pcdna3 1 pdlim7
Human Full Length Pdlim7 Expression Plasmid Pcdna3 1 Pdlim7, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human full length pdlim7 expression plasmid pcdna3 1 pdlim7/product/Addgene inc
Average 93 stars, based on 1 article reviews
human full length pdlim7 expression plasmid pcdna3 1 pdlim7 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

93
Addgene inc pdonr223 dkk1 wt
Pdonr223 Dkk1 Wt, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pdonr223 dkk1 wt/product/Addgene inc
Average 93 stars, based on 1 article reviews
pdonr223 dkk1 wt - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

90
Addgene inc myc-tagged human full length tcf4e pcdna3
Myc Tagged Human Full Length Tcf4e Pcdna3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/myc-tagged human full length tcf4e pcdna3/product/Addgene inc
Average 90 stars, based on 1 article reviews
myc-tagged human full length tcf4e pcdna3 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

93
Addgene inc full length tcf4e pcdna3
Full Length Tcf4e Pcdna3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/full length tcf4e pcdna3/product/Addgene inc
Average 93 stars, based on 1 article reviews
full length tcf4e pcdna3 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

93
Addgene inc tcf7l2 sequence
Fig. 4. <t>TCF7L2</t> dose-dependently modulates WNT/β-catenin signaling. (A) AXIN2 mRNA levels (one-way ANOVA followed by Tukey's multiple comparisons test), (B) TOPFlash promoter activity following 6 h treatment with vehicle (Veh) or 50 ng/ml WNT3A (n = 12 wells/group) (two-way ANOVA, aaaTreatment * Genotype p < 0.001, bbbTreatment P < 0.001, cccGenotype P < 0.001 followed by ˇSíd´ak's multiple comparisons test), (C) whole cell lysate active β-catenin protein levels (one-way ANOVA followed by Tukey's multiple comparisons test), and (D) TCF7 mRNA levels following TCF7L2 KD in DFAT abdominal APs and primary abdominal APs (n = 2 subjects [0F]; mean age = 45.5. Mean BMI = 29.12; rs7903146 genotype [CC]). (One-way ANOVA followed by Tukey's multiple comparisons test.) (E) TCF7 protein levels in TCF7L2 KD DFAT abdominal APs (one-way ANOVA followed by Tukey's multiple comparisons test). shCN = scrambled control, sh897 = moderate and sh843 = high TCF7L2-KD DFAT abdominal APs. Actin was used as a loading control for western blots. qRT-PCR data were normalized to 18S rRNA levels. Histograms are means ± SEM. Data obtained from 3 independent experiments. ###P < 0.001, ##P < 0.01, #P < 0.05 (adjusted for multiple comparisons).
Tcf7l2 Sequence, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tcf7l2 sequence/product/Addgene inc
Average 93 stars, based on 1 article reviews
tcf7l2 sequence - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

93
Addgene inc pcdna3 1 tcf4e plasmid
Fig. 4. <t>TCF7L2</t> dose-dependently modulates WNT/β-catenin signaling. (A) AXIN2 mRNA levels (one-way ANOVA followed by Tukey's multiple comparisons test), (B) TOPFlash promoter activity following 6 h treatment with vehicle (Veh) or 50 ng/ml WNT3A (n = 12 wells/group) (two-way ANOVA, aaaTreatment * Genotype p < 0.001, bbbTreatment P < 0.001, cccGenotype P < 0.001 followed by ˇSíd´ak's multiple comparisons test), (C) whole cell lysate active β-catenin protein levels (one-way ANOVA followed by Tukey's multiple comparisons test), and (D) TCF7 mRNA levels following TCF7L2 KD in DFAT abdominal APs and primary abdominal APs (n = 2 subjects [0F]; mean age = 45.5. Mean BMI = 29.12; rs7903146 genotype [CC]). (One-way ANOVA followed by Tukey's multiple comparisons test.) (E) TCF7 protein levels in TCF7L2 KD DFAT abdominal APs (one-way ANOVA followed by Tukey's multiple comparisons test). shCN = scrambled control, sh897 = moderate and sh843 = high TCF7L2-KD DFAT abdominal APs. Actin was used as a loading control for western blots. qRT-PCR data were normalized to 18S rRNA levels. Histograms are means ± SEM. Data obtained from 3 independent experiments. ###P < 0.001, ##P < 0.01, #P < 0.05 (adjusted for multiple comparisons).
Pcdna3 1 Tcf4e Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcdna3 1 tcf4e plasmid/product/Addgene inc
Average 93 stars, based on 1 article reviews
pcdna3 1 tcf4e plasmid - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

93
Addgene inc frank mccormick
Fig. 4. <t>TCF7L2</t> dose-dependently modulates WNT/β-catenin signaling. (A) AXIN2 mRNA levels (one-way ANOVA followed by Tukey's multiple comparisons test), (B) TOPFlash promoter activity following 6 h treatment with vehicle (Veh) or 50 ng/ml WNT3A (n = 12 wells/group) (two-way ANOVA, aaaTreatment * Genotype p < 0.001, bbbTreatment P < 0.001, cccGenotype P < 0.001 followed by ˇSíd´ak's multiple comparisons test), (C) whole cell lysate active β-catenin protein levels (one-way ANOVA followed by Tukey's multiple comparisons test), and (D) TCF7 mRNA levels following TCF7L2 KD in DFAT abdominal APs and primary abdominal APs (n = 2 subjects [0F]; mean age = 45.5. Mean BMI = 29.12; rs7903146 genotype [CC]). (One-way ANOVA followed by Tukey's multiple comparisons test.) (E) TCF7 protein levels in TCF7L2 KD DFAT abdominal APs (one-way ANOVA followed by Tukey's multiple comparisons test). shCN = scrambled control, sh897 = moderate and sh843 = high TCF7L2-KD DFAT abdominal APs. Actin was used as a loading control for western blots. qRT-PCR data were normalized to 18S rRNA levels. Histograms are means ± SEM. Data obtained from 3 independent experiments. ###P < 0.001, ##P < 0.01, #P < 0.05 (adjusted for multiple comparisons).
Frank Mccormick, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/frank mccormick/product/Addgene inc
Average 93 stars, based on 1 article reviews
frank mccormick - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

Image Search Results


Fig. 4. TCF7L2 dose-dependently modulates WNT/β-catenin signaling. (A) AXIN2 mRNA levels (one-way ANOVA followed by Tukey's multiple comparisons test), (B) TOPFlash promoter activity following 6 h treatment with vehicle (Veh) or 50 ng/ml WNT3A (n = 12 wells/group) (two-way ANOVA, aaaTreatment * Genotype p < 0.001, bbbTreatment P < 0.001, cccGenotype P < 0.001 followed by ˇSíd´ak's multiple comparisons test), (C) whole cell lysate active β-catenin protein levels (one-way ANOVA followed by Tukey's multiple comparisons test), and (D) TCF7 mRNA levels following TCF7L2 KD in DFAT abdominal APs and primary abdominal APs (n = 2 subjects [0F]; mean age = 45.5. Mean BMI = 29.12; rs7903146 genotype [CC]). (One-way ANOVA followed by Tukey's multiple comparisons test.) (E) TCF7 protein levels in TCF7L2 KD DFAT abdominal APs (one-way ANOVA followed by Tukey's multiple comparisons test). shCN = scrambled control, sh897 = moderate and sh843 = high TCF7L2-KD DFAT abdominal APs. Actin was used as a loading control for western blots. qRT-PCR data were normalized to 18S rRNA levels. Histograms are means ± SEM. Data obtained from 3 independent experiments. ###P < 0.001, ##P < 0.01, #P < 0.05 (adjusted for multiple comparisons).

Journal: Metabolism: clinical and experimental

Article Title: TCF7L2 plays a complex role in human adipose progenitor biology, which might contribute to genetic susceptibility to type 2 diabetes.

doi: 10.1016/j.metabol.2022.155240

Figure Lengend Snippet: Fig. 4. TCF7L2 dose-dependently modulates WNT/β-catenin signaling. (A) AXIN2 mRNA levels (one-way ANOVA followed by Tukey's multiple comparisons test), (B) TOPFlash promoter activity following 6 h treatment with vehicle (Veh) or 50 ng/ml WNT3A (n = 12 wells/group) (two-way ANOVA, aaaTreatment * Genotype p < 0.001, bbbTreatment P < 0.001, cccGenotype P < 0.001 followed by ˇSíd´ak's multiple comparisons test), (C) whole cell lysate active β-catenin protein levels (one-way ANOVA followed by Tukey's multiple comparisons test), and (D) TCF7 mRNA levels following TCF7L2 KD in DFAT abdominal APs and primary abdominal APs (n = 2 subjects [0F]; mean age = 45.5. Mean BMI = 29.12; rs7903146 genotype [CC]). (One-way ANOVA followed by Tukey's multiple comparisons test.) (E) TCF7 protein levels in TCF7L2 KD DFAT abdominal APs (one-way ANOVA followed by Tukey's multiple comparisons test). shCN = scrambled control, sh897 = moderate and sh843 = high TCF7L2-KD DFAT abdominal APs. Actin was used as a loading control for western blots. qRT-PCR data were normalized to 18S rRNA levels. Histograms are means ± SEM. Data obtained from 3 independent experiments. ###P < 0.001, ##P < 0.01, #P < 0.05 (adjusted for multiple comparisons).

Article Snippet: The TCF7L2 sequence (from TCF4E pcDNA3, a gift from Frank McCormick, Addgene #32738) [31] was cloned into the pCW57.1 lentiviral vector (gift from David Root, Addgene plasmid #41393) and oligonucleotides for sh843 were cloned into tet-pLKO-puro doxycyclineinducible expression lentiviral vector (gift from Dmitri Wiederschain, Addgene #21915) [32] for inducible TCF7L2 over-expression and KD respectively.

Techniques: Activity Assay, Control, Western Blot, Quantitative RT-PCR

Fig. 5. Global transcriptional profiling reveals that TCF7L2 regulates multiple aspects of AP biology. (A) Principal component analysis (PCA) of the global tran scriptomic profile of control (scrambled), moderate (sh897) and high-efficiency (sh843) TCF7L2-KD DFAT abdominal APs over 3 independent passages. (B) Venn diagram showing the overlap between differentially regulated genes from paired comparisons (FDR < 0.05). (C and D) Volcano plots showing the genes differentially regulated between control and (C) sh843 (TCF7 was one of top 30 differentially regulated genes highlighted in yellow); or (D) sh897, TCF7L2-KD DFAT abdominal APs. Highlighted are the top 30 differentially regulated genes. (E) Overrepresentation analyses of genes differentially regulated in sh843 and sh897 DFAT abdominal APs, vs. controls in gene ontology biological processes gene sets. P-value was adjusted using the FDR (Benjamini-Hochberg) procedure. Gene ratio represents the percentage of total DEGs in the given GO term. (F) Dimensional reduction of transcription factors similarity by co-regulation of targets (see Supplementary methods). Colors represent high dimensional clustering by affinity propagation. (G) Dendrogram of transcription factors Euclidean distance. (H) JUB, MEF2A and TEAD1 expression levels in high- and low-efficiency TCF7L2-KD cells (vs. scramble control) are shown. Padj is annotated for RNAseq log2 fold-change measurements. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

Journal: Metabolism: clinical and experimental

Article Title: TCF7L2 plays a complex role in human adipose progenitor biology, which might contribute to genetic susceptibility to type 2 diabetes.

doi: 10.1016/j.metabol.2022.155240

Figure Lengend Snippet: Fig. 5. Global transcriptional profiling reveals that TCF7L2 regulates multiple aspects of AP biology. (A) Principal component analysis (PCA) of the global tran scriptomic profile of control (scrambled), moderate (sh897) and high-efficiency (sh843) TCF7L2-KD DFAT abdominal APs over 3 independent passages. (B) Venn diagram showing the overlap between differentially regulated genes from paired comparisons (FDR < 0.05). (C and D) Volcano plots showing the genes differentially regulated between control and (C) sh843 (TCF7 was one of top 30 differentially regulated genes highlighted in yellow); or (D) sh897, TCF7L2-KD DFAT abdominal APs. Highlighted are the top 30 differentially regulated genes. (E) Overrepresentation analyses of genes differentially regulated in sh843 and sh897 DFAT abdominal APs, vs. controls in gene ontology biological processes gene sets. P-value was adjusted using the FDR (Benjamini-Hochberg) procedure. Gene ratio represents the percentage of total DEGs in the given GO term. (F) Dimensional reduction of transcription factors similarity by co-regulation of targets (see Supplementary methods). Colors represent high dimensional clustering by affinity propagation. (G) Dendrogram of transcription factors Euclidean distance. (H) JUB, MEF2A and TEAD1 expression levels in high- and low-efficiency TCF7L2-KD cells (vs. scramble control) are shown. Padj is annotated for RNAseq log2 fold-change measurements. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

Article Snippet: The TCF7L2 sequence (from TCF4E pcDNA3, a gift from Frank McCormick, Addgene #32738) [31] was cloned into the pCW57.1 lentiviral vector (gift from David Root, Addgene plasmid #41393) and oligonucleotides for sh843 were cloned into tet-pLKO-puro doxycyclineinducible expression lentiviral vector (gift from Dmitri Wiederschain, Addgene #21915) [32] for inducible TCF7L2 over-expression and KD respectively.

Techniques: Control, Expressing

Fig. 7. Schematic summarizing the role of TCF7L2 and impact of rs7903146 genotype on human AP biology. TCF7L2 has dose-dependent effects on adipo genesis with moderate and high-efficiency knockdown leading to enhanced and impaired adipogenesis respectively in vitro. In fractionated adipose tissue expression of TCF7L2 in APs correlates positively with donor BMI whilst the T2D risk variant (T) at rs7903146 is associated with reduced AP TCF7L2 expression. Based on these findings we speculate that lean homozygous T2D risk variant carriers would have the lowest AP TCF7L2 expression and conse quently impaired adipogenesis, larger adipocytes, increased adipo-IR and higher susceptibility to T2D compared with obese T2D risk variant carriers.

Journal: Metabolism: clinical and experimental

Article Title: TCF7L2 plays a complex role in human adipose progenitor biology, which might contribute to genetic susceptibility to type 2 diabetes.

doi: 10.1016/j.metabol.2022.155240

Figure Lengend Snippet: Fig. 7. Schematic summarizing the role of TCF7L2 and impact of rs7903146 genotype on human AP biology. TCF7L2 has dose-dependent effects on adipo genesis with moderate and high-efficiency knockdown leading to enhanced and impaired adipogenesis respectively in vitro. In fractionated adipose tissue expression of TCF7L2 in APs correlates positively with donor BMI whilst the T2D risk variant (T) at rs7903146 is associated with reduced AP TCF7L2 expression. Based on these findings we speculate that lean homozygous T2D risk variant carriers would have the lowest AP TCF7L2 expression and conse quently impaired adipogenesis, larger adipocytes, increased adipo-IR and higher susceptibility to T2D compared with obese T2D risk variant carriers.

Article Snippet: The TCF7L2 sequence (from TCF4E pcDNA3, a gift from Frank McCormick, Addgene #32738) [31] was cloned into the pCW57.1 lentiviral vector (gift from David Root, Addgene plasmid #41393) and oligonucleotides for sh843 were cloned into tet-pLKO-puro doxycyclineinducible expression lentiviral vector (gift from Dmitri Wiederschain, Addgene #21915) [32] for inducible TCF7L2 over-expression and KD respectively.

Techniques: Knockdown, In Vitro, Expressing, Variant Assay